![Sherwin Sattarzadeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sherwin Sattarzadeh
Geen lopende functies
Vermogen: 5 M $ op 30-06-2026
Profiel
Mr. Sherwin Sattarzadeh was previously employed as a Chief Executive & Operating Officer by Damora Therapeutics, Inc., a Chief Business Officer by Blueprint Medicines Corp., and a Director-Regulatory Affairs by Genzyme Corp.
He received his undergraduate degree from the University of British Columbia and an MBA from Boston University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-01-2026 | 190.376 ( 0,31% ) | 5 M $ | 30-06-2026 |
Eerdere bekende functies van Sherwin Sattarzadeh
| Bedrijven | Functie | Einde |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Algemeen Directeur | 30-03-2026 |
| BLUEPRINT MEDICINES CORPORATION | Human Resources Officer | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Algemeen Adviseur | 01-07-2015 |
Opleiding van Sherwin Sattarzadeh
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
